[1]
|
Domenico, C. and Maurizio, V. (2020) WHO Declares COVID-19 a Pandemic. Acta Biomedica Atenei Parmensis, 91, 157-160.
|
[2]
|
Zhe, X., et al. (2020) Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome. The Lancet Respiratory Medicine, 8, 420-422. https://doi.org/10.1016/S2213-2600(20)30076-X
|
[3]
|
Wichmann, D., et al. (2020) Autopsy Findings and Venous Thromboembolism in Patients with COVID-19. Annals of Internal Medicine, 173, 1030. https://doi.org/10.7326/L20-1206
|
[4]
|
Wu, Z.Y. and McGoogan, J.M. (2020) Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA, 323, 1239-1242. https://doi.org/10.1001/jama.2020.2648
|
[5]
|
Huang, C.L., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, 395, 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
|
[6]
|
Zhou, P., et al. (2020) A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature, 579, 270-273. https://doi.org/10.1038/s41586-020-2012-7
|
[7]
|
杜光, 赵杰, 卜书红, 陈娜, 陈瑞玲, 陈万生, 陈孝, 陈泳伍, 戴智勇, 杜光, 冯瑾, 高杰, 高申, 葛卫红, 郭瑞臣, 菅凌燕, 姜玲, 李峰, 李佳, 李玉萍, 刘皋林, 卢晓阳, 吕迁州, 闵光宁, 缪丽燕, 沈承武, 隋忠国, 童荣生, 王春革, 王卓, 武新安, 徐珽, 叶晓芬, 尹桃, 游一中, 张健, 张玮, 张文婷, 张晓坚, 赵杰, 赵志刚, 朱立勤, 邹东娜. 雾化吸入疗法合理用药专家共识(2019年版) [J]. 医药导报, 2019, 38(2): 135-146.
|
[8]
|
Meyerowitz, E.A., Richterman, A., Gandhi, R.T. and Sax, P.E. (2020) Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors. Annals of Internal Medicine, 174, 69-79. https://doi.org/10.7326/M20-5008
|
[9]
|
Ari, A. (2020) Practical Strategies for a Safe and Effective Delivery of Aerosolized Medications to Patients with COVID-19. Respiratory Medicine, 167, Article ID: 105987. https://doi.org/10.1016/j.rmed.2020.105987
|
[10]
|
Ignarro, L.J. (2000) Nitric Oxide: Biology and Pathobiology. Academic Press, Cambridge.
|
[11]
|
Lu, R.J., et al. (2020) Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding. The Lancet, 395, 565-574. https://doi.org/10.1016/S0140-6736(20)30251-8
|
[12]
|
Daniel, W., et al. (2020) Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation. Science (New York, N.Y.), 367, 1260-1263. https://doi.org/10.1126/science.abb2507
|
[13]
|
Schmidt, E.P., et al. (2012) The Pulmonary Endothelial Glycocalyx Regulates Neutrophil Adhesion and Lung Injury during Experimental Sepsis. Nature Medicine, 18, 1217-1223. https://doi.org/10.1038/nm.2843
|
[14]
|
Uchimido, R., Schmidt, E.P. and Shapiro, N.I. (2019) The Glycocalyx: A Novel Diagnostic and Therapeutic Target in Sepsis. Critical Care (London, England), 23, 16. https://doi.org/10.1186/s13054-018-2292-6
|
[15]
|
Cabrales, P., Tsai, A.G., Frangos, J.A. and Intaglietta, M. (2005) Role of Endothelial Nitric Oxide in Microvascular Oxygen Delivery and Consumption. Free Radical Biology and Medicine, 39, 1229-1237.
https://doi.org/10.1016/j.freeradbiomed.2005.06.019
|
[16]
|
Sara, A., et al. (2005) Nitric Oxide Inhibits the Replication Cycle of Severe Acute Respiratory Syndrome Coronavirus. Journal of Virology, 79, 1966-1969. https://doi.org/10.1128/JVI.79.3.1966-1969.2005
|
[17]
|
Zhang, R.L., et al. (2015) Hemoglobin βCys93 Is Essential for Cardiovascular Function and Integrated Response to Hypoxia. Proceedings of the National Academy of Sciences of the United States of America, 112, 6425-6430.
https://doi.org/10.1073/pnas.1502285112
|
[18]
|
Cabrales, P. (2013) Examining and Mitigating Acellular Hemoglobin Vasoactivity. Antioxidants & Redox Signaling, 18, 2329-2341. https://doi.org/10.1089/ars.2012.4922
|
[19]
|
Moncada, S. and Higgs, A. (1993) The L-Arginine-Nitric Oxide Pathway. The New England Journal of Medicine, 329, 2002-2012. https://doi.org/10.1056/NEJM199312303292706
|
[20]
|
Lee, H.-Y., Zeeshan, H.M.A., Kim, H.-R. and Chae, H.-J. (2017) Nox4 Regulates the eNOS Uncoupling Process in Aging Endothelial Cells. Free Radical Biology and Medicine, 113, 26-35.
https://doi.org/10.1016/j.freeradbiomed.2017.09.010
|
[21]
|
Csoma, B., et al. (2019) Dysregulation of the Endothelial Nitric Oxide Pathway Is Associated with Airway Inflammation in COPD. Respiratory Research, 20, Article No. 156. https://doi.org/10.1186/s12931-019-1133-8
|
[22]
|
Lopez-Sublet, M., et al. (2018) Focus on Increased Serum Angiotensin-Converting Enzyme Level: From Granulomatous Diseases to Genetic Mutations. Clinical Biochemistry, 59, 1-8. https://doi.org/10.1016/j.clinbiochem.2018.06.010
|
[23]
|
Wang, J., et al. (2015) Balance between Angiotensin Converting Enzyme and Angiotensin Converting Enzyme 2 in Patients with Chronic Heart Failure. Journal of the Renin-Angiotensin-Aldosterone System, 16, 553-558.
https://doi.org/10.1177/1470320315576257
|
[24]
|
Bateman, E.D., et al. (2018) Global Strategy for Asthma Management and Prevention: GINA Executive Summary. E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O’Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel and H.J. Zar. Eur Respir J 2008; 31: 143-178. The European Respiratory Journal, 51, Article ID: 0751387. https://doi.org/10.1183/13993003.51387-2007
|
[25]
|
Rahman, M.M. and Siddiqui, M.M.R. (2016) Global Initiative for Chronic Obstructive Lung Disease (GOLD). Anwer Khan Modern Medical College Journal, 7, 4. https://doi.org/10.3329/akmmcj.v7i1.31596
|
[26]
|
Yang, M.J., et al. (2019) Inhaled Corticosteroids and Risk of Upper Respiratory Tract Infection in Patients with Asthma: A Meta-Analysis. Infection, 47, 377-385. https://doi.org/10.1007/s15010-018-1229-y
|
[27]
|
Yang, M.J., et al. (2017) Long-Term Use of Inhaled Corticosteroids and Risk of Upper Respiratory Tract Infection in Chronic Obstructive Pulmonary Disease: A Meta-Analysis. Inhalation Toxicology, 29, 219-226.
https://doi.org/10.1080/08958378.2017.1346006
|
[28]
|
Yang, I.A., et al. (2012) Inhaled Corticosteroids for Stable Chronic Obstructive Pulmonary Disease. The Cochrane Database of Systematic Reviews, No. 7, CD002991. https://doi.org/10.1002/14651858.CD002991.pub3
|
[29]
|
Marco, C., et al. (2017) Long-Term Effects of Inhaled Corticosteroids on Sputum Bacterial and Viral Loads in COPD. The European Respiratory Journal, 50, Article ID: 1700451. https://doi.org/10.1183/13993003.00451-2017
|
[30]
|
Antonio, A., et al. (2017) Inhalation Therapies in Acute Respiratory Distress Syndrome. Annals of Translational Medicine, 5, 293. https://doi.org/10.21037/atm.2017.07.21
|
[31]
|
Ortiz-Diaz, E., et al. (2011) Preadmission Use of Inhaled Corticosteroids Is Associated with a Reduced Risk of Direct Acute Lung Injury/Acute Respiratory Distress Syndrome. Chest, 140, 912A, 912B.
https://doi.org/10.1378/chest.1110134
|
[32]
|
Emir, F., et al. (2017) Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome. Critical Care Medicine, 45, 798-805.
https://doi.org/10.1097/CCM.0000000000002284
|
[33]
|
Yamaya, M., et al. (2020) Inhibitory Effects of Glycopyrronium, Formoterol, and Budesonide on Coronavirus HCoV-229E Replication and Cytokine Production by Primary Cultures of Human Nasal and Tracheal Epithelial Cells. Respiratory Investigation, 58, 155-168. https://doi.org/10.1016/j.resinv.2019.12.005
|
[34]
|
Oliver, B.G.G., Robinson, P., Peters, M. and Black, J. (2014) Viral Infections and Asthma: An Inflammatory Interface? The European Respiratory Journal, 44, 1666-1681. https://doi.org/10.1183/09031936.00047714
|
[35]
|
Singanayagam, R., et al. (2018) Corticosteroid Suppression of Antiviral Immunity Increases Bacterial Loads and Mucus Production in COPD Exacerbations. Nature Communications, 9, Article No. 2229.
https://doi.org/10.1038/s41467-018-04574-1
|
[36]
|
Halpin, D.M.G., Singh, D. and Hadfield, R.M. (2020) Inhaled Corticosteroids and COVID-19: A Systematic Review and Clinical Perspective. The European Respiratory Journal, 55, Article ID: 2001009.
https://doi.org/10.1183/13993003.01009-2020
|
[37]
|
Horby, P., et al. (2020) Dexamethasone in Hospitalized Patients with Covid-19—Preliminary Report. The New England Journal of Medicine, 384, 693-704. https://doi.org/10.1056/NEJMoa2021436
|
[38]
|
Marmor, M.F., et al. (2016) Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology, 123, 1386-1394. https://doi.org/10.1016/j.ophtha.2016.01.058
|
[39]
|
Gautret, P., et al. (2020) Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial. International Journal of Antimicrobial Agents, 56, Article ID: 105949.
https://doi.org/10.1016/j.ijantimicag.2020.105949
|
[40]
|
Biot, C., et al. (2006) Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral Activities. Journal of Medicinal Chemistry, 49, 2845-2849. https://doi.org/10.1021/jm0601856
|
[41]
|
Colson, P., et al. (2020) Chloroquine and Hydroxychloroquine as Available Weapons to Fight COVID-19. International Journal of Antimicrobial Agents, 55, Article ID: 105932. https://doi.org/10.1016/j.ijantimicag.2020.105932
|
[42]
|
Yao, X.T., et al. (2020) In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 71, 732-739. https://doi.org/10.1093/cid/ciaa237
|
[43]
|
Albariqi, A.H., et al. (2020) Inhalable Hydroxychloroquine Powders for Potential Treatment of COVID-19. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 34, 20-31. https://doi.org/10.1089/jamp.2020.1648
|
[44]
|
Chu, D.K., et al. (2020) Physical Distancing, Face Masks, and Eye Protection to Prevent Person-to-Person Transmission of SARS-CoV-2 and COVID-19: A Systematic Review and Meta-Analysis. The Lancet, 395, 1973-1987.
https://doi.org/10.1016/S0140-6736(20)31142-9
|
[45]
|
Dhand, R. and Li, J. (2020) Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2. American Journal of Respiratory and Critical Care Medicine, 202, 651-659.
https://doi.org/10.1164/rccm.202004-1263PP
|
[46]
|
Fink, J.B., et al. (2020) Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 33, 300-304. https://doi.org/10.1089/jamp.2020.1615
|
[47]
|
Ari, A. (2020) Use of Aerosolised Medications at Home for COVID-19. The Lancet Respiratory Medicine, 8, 754-756.
https://doi.org/10.1016/S2213-2600(20)30270-8
|
[48]
|
Louis-Philippe, B., et al. (2019) The Global Initiative for Asthma (GINA): 25 Years Later. The European Respiratory Journal, 54, Article ID: 1900598. https://doi.org/10.1183/13993003.00598-2019
|
[49]
|
Halpin, D.M.G., Faner, R., Sibila, O., Badia, J.R. and Agusti, A. (2020) Do Chronic Respiratory Diseases or Their Treatment Affect the Risk of SARS-CoV-2 Infection? The Lancet Respiratory Medicine, 8, 436-438.
https://doi.org/10.1016/S2213-2600(20)30167-3
|
[50]
|
Tran, K., et al. (2013) Aerosol-Generating Procedures and Risk of Transmission of Acute Respiratory Infections: A Systematic Review. CADTH Technology Overviews, 3, e3201.
|
[51]
|
Adusumilli, N.C., et al. (2020) Harnessing Nitric Oxide for Preventing, Limiting and Treating the Severe Pulmonary Consequences of COVID-19. Nitric Oxide, 103, 4-8. https://doi.org/10.1016/j.niox.2020.07.003
|